健康照护类股ETF-SPDR(XLV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XLV 健康照护类股ETF-SPDR

交易中 06-12 12:22:52 EDT

153.59

-0.46

-0.30%

最高155.13	最低153.38	成交量526.57万
今开154.99	昨收154.05	日振幅1.14%
总市值390.90亿	流通市值390.90亿	总股本2.55亿
成交额8.11亿	换手率2.07%	流通股本2.55亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"XLV","market":"US","secType":"STK","nameCN":"健康照护类股ETF-SPDR","latestPrice":153.585,"timestamp":1781281372471,"preClose":154.05,"halted":0,"volume":5265662,"delay":0,"changeRate":-0.003018500486854939,"floatShares":254515324,"shares":254515324,"eps":-14.217021,"marketStatus":"交易中","change":-0.465,"latestTime":"06-12 12:22:52 EDT","open":154.99,"high":155.13,"low":153.38,"amount":810751239.99576,"amplitude":0.01136,"askPrice":153.62,"askSize":425,"bidPrice":153.61,"bidSize":25,"shortable":3,"etf":1,"ttmEps":-14.217021,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1781294400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":154.05,"sharesOutstanding":267365324,"nav":152.843846,"aum":39023376069.05,"dividendRate":0.015921,"bidAskSpread":0.000093,"preHourTrading":{"tag":"盘前","latestPrice":155.05,"preClose":154.05,"latestTime":"09:29 EDT","volume":6881,"amount":1064779.42676,"timestamp":1781270999999,"change":1,"changeRate":0.006491,"amplitude":0.012593},"postHourTrading":{"tag":"盘后","latestPrice":153.79,"preClose":154.09,"latestTime":"19:54 EDT","volume":35057,"amount":5402445.7792,"timestamp":1781222063922,"change":-0.3,"changeRate":-0.001947,"amplitude":0.005135},"volumeRatio":0.889195,"optionData":{"bulkOrders":[{"symbol":"XLV","call":false,"expireDate":1782446400000,"strike":"148.0","timestamp":1781275174197,"price":0.45,"volume":1125,"amount":50625,"type":"-"}]},"impliedVol":0.1681,"impliedVolPercentile":0.4223},"requestUrl":"/m/hq/s/XLV/","defaultTab":"news","newsList":[{"id":"1167341696","title":"医疗健康板块市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1167341696","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167341696?lang=zh_cn&edition=full","pubTime":"2026-06-12 04:53","pubTimestamp":1781211222,"startTime":"0","endTime":"0","summary":"在近期举行的美国糖尿病协会会议上，诺和诺德确认，口服Wegovy自推出以来已开具300万份处方。“整整82%的处方医生是体重管理领域的新手，我们认为这表明口服疗法正在帮助扩大市场。”会议还重点介绍了几项新研究，这些研究间接加强了对GLP-1疗法在体重管理中应用的支持，这可能有助于在保险公司和监管机构此前限制较多的市场（如瑞典）提高治疗可及性。股价下跌1%，至280.20丹麦克朗。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","LABU","BK4581","BK4588","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133908394","title":"医疗保健板块市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1133908394","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133908394?lang=zh_cn&edition=full","pubTime":"2026-06-12 00:23","pubTimestamp":1781194997,"startTime":"0","endTime":"0","summary":"最新一期医疗保健板块市场动态聚焦于行业内的关键讨论。SB1 Markets认为，该公司目前在口服肥胖治疗领域拥有明显优势，而礼来则在注射疗法领域占据相应领先地位。在近期举行的美国糖尿病协会会议上，诺和诺德确认，自上市以来，口服Wegovy已开出300万张处方。SB1 Markets指出：“高达82%的处方医生是体重管理领域的新手，在我们看来，这表明口服疗法正在帮助扩大市场。”诺和诺德股价下跌1%，至280.20丹麦克朗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4581","XBI","XLV","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191053663","title":"医疗保健板块热点速递：市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1191053663","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191053663?lang=zh_cn&edition=full","pubTime":"2026-06-11 16:23","pubTimestamp":1781166219,"startTime":"0","endTime":"0","summary":"最新一期聚焦医疗保健板块的市场动态速递。阿斯利康股价开盘基本持平。该公司股价下跌2.1%，至366.00印尼盾。欧洲斯托克600医疗保健指数上涨0.5%。瑞银分析师在一份研究报告中表示，葛兰素史克拟议收购Nuvalent的交易对这家英国制药商而言是绝佳匹配，并为其未来推出肺癌药物ris-rez奠定了基础。瑞银表示，这两款Nuvalent药物通过改善现有疗法的疗效和耐受性，合计有潜力实现37.5亿美元的峰值销售额。葛兰素史克股价大体持平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XBI","BK4585","LABU","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139258159","title":"医疗健康板块综述：市场热议聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1139258159","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139258159?lang=zh_cn&edition=full","pubTime":"2026-06-11 04:55","pubTimestamp":1781124902,"startTime":"0","endTime":"0","summary":"欧洲大型制药企业在今年下半年将迎来繁忙日程，数项关键事件有望助其构建积极前景并赢得投资者青睐。据美国银行分析师指出，诺华和阿斯利康在临床试验结果公布方面日程最为密集。此外，分析师补充道，葛兰素史克和赛诺菲新近任命的首席执行官预计将在第二季度财报发布之际，就其战略规划提供最新进展。对于诺和诺德，美国银行表示，市场关注焦点仍将集中在其肥胖与糖尿病产品的处方趋势上。斯托克欧洲600医疗保健指数目前上涨0.5%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","XLV","XBI","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174033257","title":"医疗健康板块综述：市场动态聚焦制药巨头与手套商","url":"https://stock-news.laohu8.com/highlight/detail?id=1174033257","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174033257?lang=zh_cn&edition=full","pubTime":"2026-06-11 00:23","pubTimestamp":1781108609,"startTime":"0","endTime":"0","summary":"欧洲大型制药公司下半年日程紧凑，一系列关键事件有望助其构建积极前景并赢得投资者青睐。他们补充道，葛兰素史克和赛诺菲新近任命的首席执行官预计将在发布第二季度财报时，同步更新其战略规划。对于诺和诺德，分析师认为其焦点仍将集中在肥胖与糖尿病产品的处方趋势上。罗氏的下半年则相对平静，但其新型乳腺癌药物giredestrant的上市将成为关键。欧洲斯托克600医疗健康指数当前上涨0.5%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4581","XBI","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156980149","title":"医疗健康板块热点速递：市场动态一览","url":"https://stock-news.laohu8.com/highlight/detail?id=1156980149","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156980149?lang=zh_cn&edition=full","pubTime":"2026-06-10 04:53","pubTimestamp":1781038402,"startTime":"0","endTime":"0","summary":"最新一期医疗健康板块市场动态速递。此次上调规模表明，市场对Apotex及其股东出售股票的需求强劲，足以支持其超越最初的计划。葛兰素史克股价下跌1.3%。瑞银分析师维持对该股的买入评级，但在给客户的报告中警告称，市场普遍预测CSL血浆制品业务利润率将扩大90个基点，这一预期过高。他们预计，每位捐赠者采集量增长10%将带来改善，并称这将有助于抵消价格和竞争压力。股价上涨0.6%至98.49澳元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4539","XLV","NUVL","BK4585","LABU","XBI","BK4581","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152725195","title":"医疗保健板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1152725195","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152725195?lang=zh_cn&edition=full","pubTime":"2026-06-09 16:23","pubTimestamp":1780993391,"startTime":"0","endTime":"0","summary":"科技股反弹抵消了医疗保健和软件板块的跌幅，泛欧斯托克600指数表现持平。伦敦富时100指数下跌0.3%，因医疗保健股走低，其中葛兰素史克在同意收购生物制药公司Nuvalent后股价下跌2.5%。软件公司励讯集团和赛捷集团均下跌约2%。银行和奢侈品集团的温和上涨助力法国CAC 40指数上扬0.3%。德国DAX指数微升0.1%，得益于半导体公司英飞凌科技股价上涨2.7%。意大利银行股延续涨势，推动米兰富时MIB指数上涨0.7%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","BK4588","XLV","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149997054","title":"医疗健康板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1149997054","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149997054?lang=zh_cn&edition=full","pubTime":"2026-06-06 00:26","pubTimestamp":1780676796,"startTime":"0","endTime":"0","summary":"最新一期医疗健康板块市场动态发布。美东时间凌晨2点06分 - 伯恩斯坦分析师在一份研究报告中指出，阿斯利康在其核心肿瘤业务之外发布的管线药物数据前景乐观，但市场似乎低估了其价值。Bell Potter表示，这一差距反映了过去几个月，在市场等待EBR启动融资期间，其股价的急剧下跌。EBR Systems股价下跌11%，报0.39澳元。（本文已进行更正，以反映EBR Systems计划以每股0.38澳元筹集1.08亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4581","BK4588","LABU","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641161560","title":"欧洲股市反弹 医疗保健板块领涨 渣打和汇丰等英国银行股下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2641161560","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641161560?lang=zh_cn&edition=full","pubTime":"2026-06-05 01:42","pubTimestamp":1780594920,"startTime":"0","endTime":"0","summary":"欧洲股市周四反弹，医疗保健股上涨，Abivax SA和Zealand Pharma A/S涨幅居前。　　斯托克欧洲600指数收盘上涨0.5%，摆脱早盘跌势。医疗保健、金融服务和零售板块领涨，矿业股和电信股表现最差。　　Abivax大涨18%，此前该股因一项关键临床试验中的癌症病例而暴跌。　　欧洲股市今年以来上涨逾5%，但仍落后于美国和亚洲市场的涨势，后两者对AI主题的敞口更大。这导致瑞银集团的一篮子AI赢家股票下跌1.6%，不过该篮子今年以来仍上涨逾40%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-05/doc-iniahnxk9041101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SPEU","LU0149534421.HKD","FEZ","VGK","LU1267930227.SGD","LU0211977185.USD","LU0211326755.USD","BK4588","BK1619","BK4521","IEUR","BK1601","LU0496365809.HKD","LU0607220059.USD","STAN.UK","LABU","BK4534","SG9999001689.USD","BK1572","LU2236285917.USD","HSBH","SG9999000327.SGD","VEA","02888","BK4581","BK1231","LU0052756011.USD","HSBC","LU0211326839.USD","03143","BK4585","BK4550","BK4504","LU0128525689.USD","EURL","IEFA","XBI","XLV","EPV","BK4207","VHT","LU0310800965.SGD","LU0976567544.SGD","IEV","FLEE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120703317","title":"医疗保健板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1120703317","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120703317?lang=zh_cn&edition=full","pubTime":"2026-06-04 00:22","pubTimestamp":1780503772,"startTime":"0","endTime":"0","summary":"0548 ET - AJ Bell的Russ Mould指出，诺和诺德在阿联酋推出其口服减肥药Wegovy是一个重要的里程碑，这标志着该公司首次在美国以外地区推出其肥胖治疗药物的口服版本。Mould称，这一点在美国市场已得到印证，口服剂型于今年初推出后，需求一直很健康。诺和诺德的主要竞争对手礼来公司已于四月宣布在阿联酋推出其自身的口服减肥药。诺和诺德股价上涨0.1%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","BK4581","LABU","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196937471","title":"医疗健康板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1196937471","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196937471?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:26","pubTimestamp":1780475203,"startTime":"0","endTime":"0","summary":"最新一期聚焦医疗健康板块的市场对话。他表示，明年公司员工将可以免费使用GLP-1药物，因为他相信这将有助于降低公司的整体医疗成本。分析师表示，负责监督和有权管辖跨地区诉讼的法官小组已将集体诉讼移交至北加州联邦法院，由法官Vince Chhabria审理。该法官在最近的听证会上对该和解方案持负面看法，并在2020年驳回了拜耳解决Roundup诉讼的尝试。拜耳股价下跌5%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XBI","XLV","BK4581","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111791195","title":"医疗健康板块市场动态汇总","url":"https://stock-news.laohu8.com/highlight/detail?id=1111791195","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111791195?lang=zh_cn&edition=full","pubTime":"2026-06-03 04:53","pubTimestamp":1780433606,"startTime":"0","endTime":"0","summary":"最新一期聚焦医疗健康领域的市场对话。他指出，服用这些减肥药的人正在购买更多浆果以确保获得足够的营养。他本人正推动 Driscoll's 为员工报销更多GLP-1类药物费用，并称明年将为员工免费提供这类药物，因为他认为这将降低公司的整体医疗成本。拜耳股价下跌5%。Paragon Care的盈利预警使其失去了一位看涨者。Bell Potter指出，Paragon Care此前9700万至1.07亿澳元的指引未包含Haju Medical。Bell Potter将Paragon Care的评级从买入下调至持有，并将其目标价大幅下调逾40%，至每股0.17澳元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","XLV","BK4585","LABU","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198010928","title":"医疗健康板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1198010928","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198010928?lang=zh_cn&edition=full","pubTime":"2026-06-03 00:24","pubTimestamp":1780417443,"startTime":"0","endTime":"0","summary":"最新一期医疗健康板块市场动态发布。分析师们就行业关键事件展开热议。该股股价下跌31%。Paragon Care的盈利预警使其失去了一位看涨者。Paragon Care目前预计2026财年收入为37亿澳元，息税折旧摊销前利润在9500万至1亿澳元之间。Bell Potter指出，Paragon Care此前给出的9700万至1.07亿澳元的指引未包含Haju Medical。他将2026财年和2027财年的每股收益预测分别下调了10%和18%。Bell Potter将Paragon Care的评级从买入下调至持有，并将其目标价大幅下调逾40%，至每股0.17澳元。Paragon Care周一收于每股0.16澳元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","BK4588","XBI","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182826648","title":"医疗健康板块综述：市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1182826648","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182826648?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:29","pubTimestamp":1780302564,"startTime":"0","endTime":"0","summary":"医疗健康板块最新市场动态一览。然而，公司的核心业务依然稳健，目前其价值被低估且受到忽视。该公司股价下跌0.4%，报174.45欧元。这家印度公司正将其在国内资本效率高的店中店模式及公私合营模式复制到海外市场。上午5点42分——在加拿大皇家银行资本市场看来，Pro Medicus新合同的期限被视为好消息。加拿大皇家银行给予该股与大市同步评级，目标价为195.00澳元。该股上涨8.1%，报142.95澳元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","XBI","BK4585","BK4581","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639607386","title":"国家医保局发布2026年国家医保目录调整工作方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2639607386","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639607386?lang=zh_cn&edition=full","pubTime":"2026-05-31 10:19","pubTimestamp":1780193940,"startTime":"0","endTime":"0","summary":"自2027年开始，截止日期将确定为方案发布之日","market":"us","thumbnail":"https://img3.gelonghui.com/f3af3-4ae020e2-682d-46bb-8d75-0673a1077883.jpg?guru_height=3384&guru_width=4608&guru_size=1145570","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/f3af3-4ae020e2-682d-46bb-8d75-0673a1077883.jpg?guru_height=3384&guru_width=4608&guru_size=1145570"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4990180","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["XBI","XLV","BK4585","LABU","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639960204","title":"国家医保局发布2026年国家医保目录调整工作方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2639960204","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639960204?lang=zh_cn&edition=full","pubTime":"2026-05-31 09:20","pubTimestamp":1780190400,"startTime":"0","endTime":"0","summary":"据央视新闻消息，国家医保局今天发布《2026年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整工作方案》《2026年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整申报指南》《谈判药品续约规则》以及《非独家药品竞价规则》。同时，为帮助社会各界加深对政策的理解，组织编制了《国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整常用问答》。","market":"hk","thumbnail":"https://media.bjnews.com.cn/cover/2024/12/23/5535172268222656082.jpeg?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2024/12/23/5535172268222656082.jpeg?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1780190346129721.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1780190346129721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["BK4581","BK4585","BK4588","XBI","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639648130","title":"金元顺安医疗健康混合A基金经理变动：增聘韩辰尧为基金经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2639648130","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639648130?lang=zh_cn&edition=full","pubTime":"2026-05-29 09:53","pubTimestamp":1780019637,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年5月29日，金元顺安医疗健康混合发布公告，增聘韩辰尧为基金经理，任职日期自2026年5月29日起，陈铭杰不再担任该基金基金经理，离任日期为2026年5月29日，变更后金元顺安医疗健康混合的基金经理为张海东,韩辰尧。2022年05月加入金元顺安基金管理有限公司。2023年3月1日任金元顺安成长动力灵活配置混合型证券投资基金、金元顺安价值增长混合型证券投资基金基金经理。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202605/29/20260529636636.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202605/29/20260529636636.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260529/32263775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4581","IXJ","BK4550","159760","XLV","BK4588","LABU","XBI","VHT","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638353496","title":"Labcorp将出席Jefferies全球医疗保健大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2638353496","media":"环球市场播报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638353496?lang=zh_cn&edition=full","pubTime":"2026-05-28 04:00","pubTimestamp":1779912036,"startTime":"0","endTime":"0","summary":"全球领先的综合实验室服务提供商Labcorp Holdings Inc．今日宣布，公司将出席2026年Jefferies全球医疗保健大会并发表演讲。会议将于6月3日在纽约举行，公司演讲定于美国东部时间下午12时15分开始。　　Labcorp是一家业务覆盖约100个国家、拥有近71，000名员工的全球实验室服务巨头，为全球患者每年进行数亿次检测。　　根据公司2026年第一季度财报，Labcorp业绩表现强劲。　　本次会议演讲将通过网络直播，投资者可通过Labcorp投资者关系网站访问。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-28/doc-inhzksma8866144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["BK4585","BK4550","LABU","XLV","BK4588","BK4581","XBI","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638638727","title":"AngioDynamics将出席高盛第47届全球医疗保健年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2638638727","media":"环球市场播报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638638727?lang=zh_cn&edition=full","pubTime":"2026-05-28 03:02","pubTimestamp":1779908523,"startTime":"0","endTime":"0","summary":"医疗技术公司AngioDynamics今日宣布，公司管理团队将出席高盛第47届全球医疗保健年会并发表演讲。会议将于2026年6月10日举行，公司演讲定于美国东部时间上午9时20分开始。　　AngioDynamics是一家专注于恢复人体血管系统健康血流、拓展癌症治疗方案并改善患者生活质量的变革性医疗技术公司。其中医疗技术业务净销售额为3730万美元，同比增长19.0%，Auryon销售额增长17.9%，血栓管理业务增长17.9%，NanoKnife销售额增长21.0%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-28/doc-inhzknce0518623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["LU1868836757.USD","LU2471134952.CNY","GSX","GS","LU0345770993.USD","LU1868837136.USD","BK4552","LU1868836591.USD","IE00B19Z3581.USD","BK4588","IE00B19Z3B42.SGD","BK4550","LU1894683348.USD","LU1668664300.SGD","LU2237443465.HKD","IE00BSNM7G36.USD","BK4533","LU2237443382.USD","LU0061475181.USD","IE0002270589.USD","IE0034235188.USD","VHT","LU0742534661.SGD","LU1868837300.USD","LU2471134796.USD","LU0106831901.USD","LU2237438978.USD","BK4516","LABU","BK4585","LU0096364046.USD","BK4504","XLV","LU2750360641.GBP","BK4581","LU1894683264.USD","LU2237443549.SGD","LU1791807156.HKD","LU0868494617.USD","LU0942090050.USD","LU1868836914.USD","XBI","IE00BFXG1179.USD","LU0251142724.SGD","LU2237443978.SGD","LU0251131958.USD","LU2237443895.HKD","LU2471134879.HKD","LU0345770308.USD","LU0048573561.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183915257","title":"医疗保健板块市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1183915257","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183915257?lang=zh_cn&edition=full","pubTime":"2026-05-28 00:22","pubTimestamp":1779898974,"startTime":"0","endTime":"0","summary":"医疗保健领域的最新市场对话。新西兰时间21时37分：费雪派克医疗凭借其运营杠杆效应和不断变化的临床实践，继续成为麦格理银行的首选标的之一。麦格理将费雪派克在新西兰上市股票的目标价下调4.6%，至43.70新西兰元。该股目前上涨1.6%，报37.30新西兰元。Ryman股价上涨2.7%，至2.28新西兰元。在其调查的GLP-1药物使用者中，61%的受访者减少了热量摄入，37%的人减少了外出就餐频率，约半数人转向食用更健康的食品。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","BK4588","LABU","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://us.spdrs.com/etf/health-care-select-sector-spdr-fund-XLV","stockEarnings":[{"period":"1week","weight":0.0132},{"period":"1month","weight":0.0565},{"period":"3month","weight":0.0287},{"period":"6month","weight":0.0002},{"period":"1year","weight":0.1351},{"period":"ytd","weight":-0.0046}],"compareEarnings":[{"period":"1week","weight":-0.0255},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.114},{"period":"6month","weight":0.0821},{"period":"1year","weight":0.2268},{"period":"ytd","weight":0.0819}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"本基金追踪标普健康板块指数(S&P Health Care Select Sector index)，并将95%以上的资产投资在该指数包含的成分股，其中包含了医疗保健、生物科技、制药相关的公司。\n风险提示：标的成分和权重，有可能随着时间的迁移而发生变化。","yearOnYearQuotes":[{"month":1,"riseRate":0.607143,"avgChangeRate":0.009527},{"month":2,"riseRate":0.571429,"avgChangeRate":-0.002019},{"month":3,"riseRate":0.571429,"avgChangeRate":0.0058},{"month":4,"riseRate":0.535714,"avgChangeRate":0.012982},{"month":5,"riseRate":0.678571,"avgChangeRate":0.005168},{"month":6,"riseRate":0.535714,"avgChangeRate":0.003807},{"month":7,"riseRate":0.62963,"avgChangeRate":0.011509},{"month":8,"riseRate":0.555556,"avgChangeRate":0.001611},{"month":9,"riseRate":0.37037,"avgChangeRate":-0.015959},{"month":10,"riseRate":0.592593,"avgChangeRate":0.007405},{"month":11,"riseRate":0.777778,"avgChangeRate":0.02456},{"month":12,"riseRate":0.666667,"avgChangeRate":0.010581}],"exchange":"ARCA","name":"健康照护类股ETF-SPDR","nameEN":"Health Care Select Sector SPDR Fund"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"健康照护类股ETF-SPDR(XLV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供健康照护类股ETF-SPDR(XLV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"健康照护类股ETF-SPDR,XLV,健康照护类股ETF-SPDR股票,健康照护类股ETF-SPDR股票老虎,健康照护类股ETF-SPDR股票老虎国际,健康照护类股ETF-SPDR行情,健康照护类股ETF-SPDR股票行情,健康照护类股ETF-SPDR股价,健康照护类股ETF-SPDR股市,健康照护类股ETF-SPDR股票价格,健康照护类股ETF-SPDR股票交易,健康照护类股ETF-SPDR股票购买,健康照护类股ETF-SPDR股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"健康照护类股ETF-SPDR(XLV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供健康照护类股ETF-SPDR(XLV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}